Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 926

DECLARATION Of William G. Gaede in Support of Amgen Inc.'s Motion In Limine No. 22 to Preclude Roche from Introducing, Including in its Invalidity Opening, Testimony, Evidence or Argument on Pegylation During the Validity Phase of the Trial and to Exclude Any Proffered Testimony by Dr. Robert Langer During the Trial by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3-1# 4 Exhibit 3-2# 5 Exhibit 4)(Gottfried, Michael)

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Doc. 926 Case 1:05-cv-12237-WGY Document 926 Filed 08/31/2007 Page 1 of 3 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS AMGEN INC., Plaintiff, v. F. HOFFMANN-LA ROCHE LTD, a Swiss Company, ROCHE DIAGNOSTICS GMBH, a German Company, and HOFFMANN LA ROCHE INC., a New Jersey Corporation, Defendants. ) ) ) ) ) ) ) ) ) ) ) ) ) ) Civil Action No.: 1:05-CV-12237 WGY DECLARATION OF WILLIAM G. GAEDE, III IN SUPPORT OF PLAINTIFF AMGEN INC.'S MOTION IN LIMINE NO. 22 TO PRECLUDE ROCHE FROM INTRODUCING, INCLUDING IN ITS INVALIDITY OPENING, TESTIMONY, EVIDENCE OR ARGUMENT ON PEGYLATION DURING THE VALIDITY PHASE OF THE TRIAL AND TO EXCLUDE ANY PROFFERED TESTIMONY BY DR. ROBERT LANGER DURING THE TRIAL I, William G. Gaede, III, declare as follows: 1. I am a partner with McDermott Will & Emery LLP and counsel for Amgen, Inc. in the above-captioned matter. 2. I am submitting this declaration in support of Plaintiff Amgen Inc.'s Motion in Limine No. 22 to Preclude Roche from Introducing Testimony, Evidence or Argument on Pegylation During the Validity Phase of the Trial and to Exclude Any Proffered Testimony by Dr. Robert Langer During the Trial. 3. I have knowledge of the following, and if called as a witness, could and would testify competently to the contents herein. 4. Attached as Exhibit 1 is a true and correct copy of relevant pages from the Expert Report of Dr. Robert Langer, dated April 6, 2007, submitted on behalf of Roche in this case. MPK 131658-1.041925.0023 1 GAEDE DECL. RE AMGEN'S M/LIMINE RE PEGYLATION DURING VALIDITY PHASE CIVIL ACTION NO. 1:05-CV-12237 WGY Dockets.Justia.com Case 1:05-cv-12237-WGY Document 926 Filed 08/31/2007 Page 2 of 3 5. Attached as Exhibit 2 is a true and correct copy of relevant pages of the June 18, 2007 deposition of Dr. Langer taken in this case. 6. Dr. Langer provided no opinions in his report or deposition relating to infringement or inequitable conduct. 7. Attached as Exhibit 3 is a true and correct copy of relevant pages of the March 28, 2007 deposition of Graham Molineux taken in this case. 8. Attached as Exhibit 4 is a true and correct copy of relevant pages of the March 29, 2007 deposition of Stephen Elliott taken in this case. I declare, under penalty of perjury, under the laws of the United States, that the foregoing is true and correct and that this Declaration was completed at Palo Alto, California this 31ST day of August 2007. /s/William G. Gaede, III William G. Gaede, III MPK 131658-1.041925.0023 2 GAEDE DECL. RE AMGEN'S M/LIMINE RE PEGYLATION DURING VALIDITY PHASE CIVIL ACTION NO. 1:05-CV-12237 WGY Case 1:05-cv-12237-WGY Document 926 Filed 08/31/2007 Page 3 of 3 CERTIFICATE OF SERVICE I hereby certify that this document filed through the Electronic Case Filing (ECF) system will be sent electronically to the registered participants as identified on the Notice of Electronic Filing (NEF) and paper copies will be sent to those indicated as non registered participants on the above date. /s/ Michael R. Gottfried Michael R. Gottfried MPK 131658-1.041925.0023 1 PROOF OF SERVICE CIVIL ACTION NO. 1:05-CV-12237 WGY

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?